Mochi Health vs. ShedRx: prices, fine print, and the honest verdict

Tirzepatide pricing

On tirzepatide, Mochi Health is the cheaper program at $278 a month all-in versus ShedRx's $289 — a gap of $11 a month, $132 a year, at the 10 mg maintenance basis. Mochi Health: $278 a month all-in at the 10 mg maintenance basis, flat at every dose from 2.5 to 15 mg, including the mandatory $79/mo membership. ShedRx: $289 a month all-in at the 10 mg maintenance basis, dose-scaled from a $199 entry, no membership fee.

Semaglutide pricing

On semaglutide, Mochi Health wins at $178 versus $249 all-in — $71/mo apart. Mochi Health: Semaglutide runs $178 a month all-in. ShedRx: Semaglutide runs $249 a month all-in at the standing rate ($175 on intro/plan terms).

Transparency

Mochi Health: Source-verified (verified 2026-08-05); names its pharmacy — company-owned compounding facility. ShedRx: Source-verified (verified 2026-08-05); dispensing pharmacy not publicly named. In this market, a named pharmacy and a dated, source-verified price are worth real money — they are what let you check the claim instead of trusting it.

Commitment & cancellation

Mochi Health: membership recurs monthly; cancel membership any time; recurs until cancelled; $79/mo membership recurs until cancelled. ShedRx: none month-to-month; 72-hour notice before the next billing cycle.

The gap, compounded over time

A $11/month difference sounds decidable by coin flip until it's annualized: choosing ShedRx over Mochi Health at the standing rates costs an extra one month, $11; six months, $66; a year, $132; two years of maintenance, $264. Every figure is the all-in maintenance basis; the arithmetic reruns from the dataset.

The 24-month ledger

Zoom to the horizon that matters for a chronic-use drug — 24 months — and Mochi Health bills $6,672 and ShedRx $6,936, a spread of $264 for the same molecule at the same 10 mg basis. Reference rails for the same 24 months: $5,160 at the verified floor, $10,776 on brand Zepbound at maintenance, $8,376 on Wegovy flat.

Two ladders, side by side

The 2.5-to-10 mg climb is the honest stress test: Mochi Health holds $278 on every rung (four-month titration: exactly $1,112); ShedRx scales $199 → ~$289 by 10 mg (titration lands between $796 and $1,156). A flat ladder makes dose decisions purely clinical; a scaled one attaches an invoice to every escalation — including the post-plateau bump from 10 to 12.5 mg that many patients eventually face. Full framework: the titration cost guide.

Three buyers, two invoices

The month-one starter pays $278 at Mochi Health versus $199 at ShedRx for the 2.5 mg rung — an early edge that reverses once the ladder climbs. The settled 10 mg maintainer — the buyer our basis is built for — pays $3,336/year at Mochi Health against $3,468 at the other: $132 of annual daylight for the same molecule and dose.

The semaglutide board

Mochi Health takes the semaglutide board too at $178 versus $249 all-in — a $71/month, $852/year spread. Both sit against a verified field floor of $133 and Wegovy's flat $349 brand rate; dual-molecule pricing also sets each program's internal switch cost when a plateau raises the tirzepatide question.

The five normalizations, applied to this pair

1 · All-in, not advertised. Mochi Health's ranked figure is $278 ($199 medication + $79 mandatory membership); ShedRx's ranked figure is $289, with no membership to add. 2 · Maintenance basis. Mochi Health is dose-flat, so its entry and 10 mg figures coincide; ShedRx scales from $199 to $289, and the 10 mg figure is the one ranked. 3 · Terms separated. Mochi Health: standing $278, no prepaid tier; ShedRx: standing $289, no prepaid tier — standing rates rank, prepaid effectives are labeled beside them. 4 · Evidence tiered. Mochi Health: source-verified, read 2026-08-05; ShedRx: source-verified, read 2026-08-05. 5 · Pharmacy weighed. Mochi Health names company-owned compounding facility; ShedRx names no pharmacy — in a pharmacy-variance market, disclosure is a scored asset. Run the same five on any roundup you read and most published “cheapest” lists reorder themselves.

Fine print, itemized

Mochi Health: a mandatory $79/mo membership folded into our all-in figure; cancel membership any time; recurs until cancelled; commitment: membership recurs monthly. ShedRx: no membership — the medication figure is the billed figure; 72-hour notice before the next billing cycle; commitment: none month-to-month. The pattern to police on both sides is the same: memberships that outlive the medication order, renewal-relative cancellation deadlines, and prepaid terms whose refund language matters more than their discount in a year of live litigation. Cancel in writing; screenshot everything.

Transparency, audited

Mochi Health carries source-verified pricing (last read 2026-08-05); pharmacy disclosure is its strong suit — company-owned compounding facility, owned facility. ShedRx carries source-verified pricing (last read 2026-08-05); its dispensing pharmacy is not publicly named, so the five pharmacy questions (name, 503A/503B status, state licensure, certificate of analysis, formulation) are your pre-purchase homework. Our weighting is unapologetic: in a market of identical molecule names, a dated source-verified price and a named pharmacy are the two claims a buyer can actually check, and they carry 25 of 100 formula points between them — the methodology shows the math, and the pharmacy guide decodes every answer the five questions can return.

Switching between them

Neither program locks the door: a Mochi Health-to-ShedRx move is a new intake, a new prescription at the new pharmacy, and a written cancellation at the old shop — typically a one-to-two-week overlap if you time the last fill. What does not move with you: prepaid months, membership balances, and any dose paperwork, so re-state your current rung clearly at the new intake.

Refills, shipping, and the week-to-week reality

Past the pricing page, the operational facts are what a subscriber lives with: Mochi Health: shipping included; consultation video visits included in membership; video visit model. ShedRx: shipping included; consultation included; async visit model. Cold-chain shipments run 3–7 days across the market; the recurring failure modes are refill-timing gaps and pharmacy backlogs, so whichever program wins here, order refills a week early and confirm the pharmacy’s current turnaround at intake.

Who should pick which

Pick Mochi Health if the $11/month tirzepatide saving is the point; the semaglutide line is cheaper here; you want a price that survives titration; a named pharmacy is non-negotiable for you. Pick ShedRx if you refuse membership fees on principle. Neither answer is universal — which is the argument for choosing from data with dates on it rather than from whichever ad loaded first.

If neither one fits

Two programs never exhaust the market — the nearest substitutes on the verified board are IVIM Health at $278 (dose-scaled, $75 membership included); Found at $289 (flat, no membership); OrderlyMeds at $299 (flat, no membership) — or skip straight to the rankings page, where every standard “cheapest / best / no-commitment” question is answered in one sourced sentence.

The brand benchmark both must beat

Neither program exists in a vacuum: FDA-approved Zepbound sits at $449/month at maintenance (LillyDirect or retail KwikPens, ~$350 on TrumpRx, ~$50 for newly eligible Medicare patients), and Wegovy at a flat $349. The cheaper of these two compounded options saves $2,052/year against the Zepbound benchmark — the number that has to justify accepting a not-FDA-reviewed product, per the full trade analysis. When a compounded quote drifts above ~$350, this benchmark starts winning the argument on its own.

The verdict

On the numbers alone, Mochi Health is the cheaper tirzepatide program by $11/mo and it doesn't trade that price for opacity. Both records, with dates and sources, live in the pricing database.